HADI DOURRA: Open Payments
NPI 1003975517 · REDFORD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,703 in 92 payments from 15 companies in 2025. Trend: 2023 $807 · 2024 $1,032 · 2025 $1,703
Food & beverage: $1,703
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $492 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $264 |
| Novo Nordisk Inc | 11 | $190 |
| GlaxoSmithKline, LLC. | 14 | $168 |
| PFIZER INC. | 7 | $137 |
| ABBVIE INC. | 4 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
| Lilly USA, LLC | 3 | $53 |
| Exact Sciences Corporation | 2 | $46 |
| Axsome Therapeutics, Inc. | 2 | $44 |
Products named: CAPLYTA, FARXIGA, NURTEC ODT, TRELEGY ELLIPTA, Wegovy, Rybelsus, JARDIANCE, AIRSUPRA.
Industry payments across MI — which companies pay providers there.
